drugset / Trial / NCT07563491

Comparison of Esomeprazole Versus Vonoprazan in Gastroesophageal Reflux Disease

NCT07563491

Completed 824 enrolled Muhammad Aamir Latif
RandomizedParallel-groupOpen-labelTreatment

Summary

Local literature is deprived of data comparing the effectiveness of esomeprazole and vonoprazan in patients with gastroesophageal reflux disease (GERD). This study was planned with the objective of comparing the effectiveness of esomeprazole versus vonoprazan in patients diagnosed with GERD.

Timeline

Start
2025-01-01
Primary completion
2025-09-30
Completion
2025-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 20 mg
Subject Vonoprazan Other / unclassified 20 mg